An Overview of Cutaneous Fibrohistiocytic & (Myo)fibroblastic tumors

แชร์
ฝัง
  • เผยแพร่เมื่อ 17 ม.ค. 2025

ความคิดเห็น • 9

  • @madhuk5449
    @madhuk5449 2 หลายเดือนก่อน

    Your videos are an eye opener. Teaches us to update. On Tuesday, in dermpedia session, you showed ALK rearranged granular cell tumour. This was awesome.

  • @madhuk5449
    @madhuk5449 2 หลายเดือนก่อน

    You are a good soul.

  • @madhuk5449
    @madhuk5449 2 หลายเดือนก่อน

    Too good, thanks

  • @madhuk5449
    @madhuk5449 2 หลายเดือนก่อน

    DF with monster cells. Is it same as Atypical dermatofibroma. Bernie called them as DF with monster cells.

  • @ΘεόδωροςΤζιγκαλίδης
    @ΘεόδωροςΤζιγκαλίδης 3 ปีที่แล้ว

    Thank you for yet another remarkable and extremely useful lesson. I would like to make a question. Is diffuse positivity for p53 diagnostically helpful for the fibrosarcomatous transformation of a DFSP ? Thank you in advance.

    • @klinos
      @klinos  3 ปีที่แล้ว +2

      I do not usually use it. I believe the interpretation of fibrosarcomatous transformation is a morphological one. Colleagues have described p53 diffuse positivity in FS-DFSP. Everytime I used it was not helpful. I suspect if there is a diffuse positivity you should scrutinize the tumor but I would not rely on this one way or the other. I don't think you need any IHC for the interpretation of FS-DFSP and if you rely on IHC it is almost certain that eventually a mistake will happen.

    • @ΘεόδωροςΤζιγκαλίδης
      @ΘεόδωροςΤζιγκαλίδης 3 ปีที่แล้ว

      @@klinos thank you for the advice.

  • @madhuk5449
    @madhuk5449 2 หลายเดือนก่อน

    Bernie always considered DFSP as benign not sarcoma

  • @madhuk5449
    @madhuk5449 2 หลายเดือนก่อน

    With molecular classification, morphological interpretation is getting ambiguous / not apt.